The Union Public Service Commission (UPSC) has recommended the name of Dr Rajeev Singh Raghuvanshi as the new Drugs Controller General of India (DCGI). Last week, the UPSC conducted interviews for the appointment of the DCGI, with the top contenders being Dr. VG Somani, Dr Rajeev Singh Raghuvanshi, and Dr Jai Prakash.
Earlier, ANI reported that the final name would be announced soon. On November 11, last year, Dr VG Somani's term as DCGI was extended for three months, coming into effect on November 16, 2022. This was done for the second time, as he had also gotten an extension in the month of August 2022.
Dr Kiran Kumar Karlapu, Deputy Secretary of the Department of Health and Family Welfare, issued the circular regarding the extension of DCGI for a further period of three months. Dr VG Somani was appointed as the Drugs Controller General of India in the month of August 2019.
DCGI heads the Central Drugs Standard Control Organisation (CDSCO), which is responsible for ensuring the quality of drug supply across the country. It also has the authority to give approval to new drugs and regulate clinical trials.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Featured Video Of The Day
Homeless Black Man, Carrying Knives, Shot Dead By Cops Outside Republican Event
UPSC CMS Examination 2024 Today, Check Key Guidelines UPSC Combined Medical Services Exam 2024 To Be Held On July 14, Check Guidelines UPSC Combined Medical Services Exam 2024 Admit Card Released, Check Full Details Travel Influencer Aanvi Kamdar Dies After Falling Off A Waterfall Near Mumbai Amid Huge Row, Karnataka Pauses Bill For Reservation In Private Sector Firms Trainee IAS Summoned By Pune Cops Over Harassment Claims Against Collector Maharashtra Government Declares Job Training And Stipend Scheme Three Indians On Global Student Prize 2024 Top 50 shortlist Prime Accused In INDIA's Bihar Ally's Brutal Murder Arrested Track Latest News Live on NDTV.com and get news updates from India and around the world.